More

    The Apple Watch is helping Afib patients ditch blood thinners in a ground-breaking trial


    A hospital in Pittsburgh has become the latest medical center to join a ground-breaking Apple Watch trial in the US that’s helping patients with atrial fibrillation ditch blood-thinning medication.

    The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the overall participants) wear an Apple Watch for 14 hours a day, paired with an iPhone pre-programmed to monitor irregular heart rhythms.

    https://cdn.mos.cms.futurecdn.net/KLmRqdB9qgGmjDgLQ9riFR-1200-80.jpg



    Source link
    stephen.warwick@futurenet.com (Stephen Warwick)

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img